Stellar Capital Management’s Edwards Lifesciences EW Stock Holding History

Stellar Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$877K	Hold	12,690	–	–	0.6%	44
2020 Q1	$798K	Sell	12,690 -1,200	-9%	-$86.5K	0.66%	44
2019 Q4	$1.08M	Hold	13,890	–	–	0.63%	42
2019 Q3	$1.02M	Sell	13,890 -21	-0.2%	-$1.48K	0.66%	43
2019 Q2	$887K	Hold	13,911	–	–	0.58%	45
2019 Q1	$887K	Buy	13,911 +21	+0.2%	+$1.2K	0.58%	45
2018 Q4	$710K	Hold	13,890	–	–	0.56%	45
2018 Q3	$806K	Hold	13,890	–	–	0.52%	48
2018 Q2	$674K	Hold	13,890	–	–	0.44%	48
2018 Q1	$646K	Buy	+13,890	New	+$603K	0.42%	49
2017 Q4	–	Sell	-13,890	Closed	-$506K	–	77
2017 Q3	$506K	Hold	13,890	–	–	0.36%	56
2017 Q2	$547K	Hold	13,890	–	–	0.4%	54
2017 Q1	$436K	Hold	13,890	–	–	0.33%	60
2016 Q4	$434K	Buy	+13,890	New	+$450K	0.36%	57
2016 Q2	$422K	Hold	12,690	–	–	0.46%	49
2016 Q1	$373K	Hold	12,690	–	–	0.41%	53
2015 Q4	$334K	Hold	12,690	–	–	0.4%	54
2015 Q3	$301K	Hold	12,690	–	–	0.39%	54
2015 Q2	$301K	Sell	12,690 -2,400	-16%	-$54.2K	0.33%	55
2015 Q1	$358K	Sell	15,090 -35,340	-70%	-$793K	0.35%	56
2014 Q4	$1.07M	Sell	50,430 -810	-2%	-$16.3K	1.15%	39
2014 Q3	$872K	Sell	51,240 -300	-0.6%	-$4.74K	0.96%	41
2014 Q2	$737K	Buy	51,540 +1,770	+4%	+$24K	0.81%	41
2014 Q1	$615K	Buy	49,770 +1,770	+4%	+$20.4K	0.69%	46
2013 Q4	$526K	Buy	+48,000	New	+$541K	0.56%	52

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Stellar Capital Management's EW Position: Q2 2020 in Review

Stellar Capital Management held its Edwards Lifesciences (EW) position steady in Q2 2020 at 12,690 shares worth $877K. The position accounts for 0.6% of the portfolio, ranked #44.

Stellar Capital Management first reported a position in EW in Q4 2013 and has held it in 25 quarters since. The position peaked at $1.08M in Q4 2019. 1,047 funds tracked by Wall St. Rank hold EW as of Q2 2020.

Stellar Capital Management held 12,690 shares of Edwards Lifesciences worth $877K as of Q2 2020.
Stellar Capital Management left its Edwards Lifesciences share count unchanged in Q2 2020.
Edwards Lifesciences made up 0.6% of Stellar Capital Management's portfolio in Q2 2020, its #44 holding.
Stellar Capital Management first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 25 quarters since.
Stellar Capital Management's Edwards Lifesciences position peaked at $1.08M in Q4 2019.
1,047 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Stellar Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.